To Purchase NanobacTX, Go to the bottom of this page.

NanobacTX is a patented non-prescription all-oral nanobiotic compound shown in published cardiology studies to reverse arteriosclerosis, calcified coronary artery disease plaque volume and heart disease symptoms. NanobacTX is shown to dissolve, eradicate and regress calcified artery plaque and calcification deposits in blood vessels, organs and tissues. Our published cardiology studies show that NanobacTX decreases heart disease symptoms, chest pain and increases exercise ability while alleviating inflammation, coronary artery calcification and improving coronary artery blood flow and vascular flexibility. NanobacTX decreases calcified arterial and coronary artery plaque volume after 6-12 months of nightly treatment.

"I know of no other treatment that is so successful."- Cardiologist StephenSinatra,MD,FACC ("NanobacTX - Major Breakthrough in Arterial Health" - The Sinatra Report)

NanobacTX therapy improvement is a time-dependent process, meaning that the more severe your coronary artery disease and the greater your coronary artery calcification (Density & Area), the longer your nightly NanobacTX therapy will need to be continued. Most people notice marked subjective improvement in their cardiac symptoms in as little as 7-10 days, but externally-measurable improvement on stress-testing and HeartScan CAC Scoring generally requires 6-12 months of nightly therapy. Although the basic science & clinical research has been published in prominent, respected, peer-reviewed medical journals, the reality is that most physicians do not read their scientific medical journals. We do not have pharmaceutical representatives to educate them about NanobacTX. For both reasons, not all physicians are familiar with our research and NanobacTX. We encourage you to personally hand or EMail our studies to your physician. Our studies show that NanobacTX does not interfere with existing medical therapy or meds (except for digitalis). As your condition improves with NanobacTX, it is not uncommon for your physician to adjust or eliminate previously required meds.

Clinicians Note: The NanobacTX-ACES PILOT STUDY was conducted without Tetracycline Hcl use. We added tetracycline to the regimen for the NanobacTX-ACES Cardiology Study, as we discovered that tetracycline was lethal to CNPs/Nanobacteria in vitro (pure cultures). The clinical trial results between the NanobacTX-ACES PILOT STUDY and the NanobacTX-ACESII Cardiology Trial were essentially identical, with results WITHOUT tetracycline slightly superior, we no longer recommend the use of Tetracycline Hcl. NanobacTX is shown effective by itself, and is lethal to CNPs/Nanobacteria in culture and in clinical trials (In Vitro & In Vivo).

Click HERE to read Full NanobacTX-ACESII Cardiology Trial by Dr. Maniscalco, et al

Click HERE to read published Scientific & NanobacTX Summary Studies by Mezo, et al 

NanobacTX is a non-prescription ALL-ORAL nutraceutical preparation that is patented. NanobacTX consists of enzyme systems, amino acids, antioxidants, sequestrants and carriers designed to synergistically decrease pathological calcification, soft plaque volume and inflammation in arteriosclerotic blood vessels, coronary arteries and throughout the body, head-to-toe. NanobacTX is specifically designed to be taken every night at bedtime when it is most effective: during your sleep. Depending upon your diagnosis & severity, the initial course of therapy is 6-12 months of continuous nightly treatment. After a core treatment of 6-12 months, a maintenance program is recommended to avoid relapse. The maintenance program consists of using 2 NanobacTX capsules per night (instead of the regular 8/night in full therapy) on an ongoing basis. 

In addition to arteriosclerosis and cardiovascular disorders, patients and physicians have reported additional improvement in other health disorders with NanobacTX. Since all tissues and organs require ongoing blood supply for health, it is not surprising to see improvement wherever blood flows. Many chronic diseases conditions arise later in life secondary to progressive arteriosclerosis in tissues and organs. This effect is also seen endocrine organ atrophy and subsequent decreased hormone levels as we age.

Coronary Artery Disease + Alzheimer's Disease Testimonial: "My sister was treated with NanobacTX for her heart disease for 4 months. Not only did her heart disease status improve, but so did her Alzheimer's Disease! She had been confined to a nursing home for her Alzheimer's because she was no longer capable of caring for herself at home and she did not know who were were.....but after 4 months of NanobacTX, she knew who we were, and was able to return to her home and live by herself successfully"-Richard F. (minister & attorney) 

Purchase NanobacTX here with a CREDIT CARD:

NanobacTX - 1 Unit (30 Day Supply) = $199.00.

↓ Enter into the box below the number of units to order, then click the Cart button....    

________________________________________________________

NanobacTX-3 Pack (90 Day Supply) = $537.00 (Save $60.00)